Northwest Investment Counselors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $103K | Buy |
+3,556
| New | +$103K | 0.02% | 184 |
|
2024
Q2 | – | Sell |
-3,194
| Closed | -$88.6K | – | 404 |
|
2024
Q1 | $88.6K | Buy |
+3,194
| New | +$88.6K | 0.02% | 190 |
|
2023
Q4 | – | Sell |
-7,356
| Closed | -$244K | – | 424 |
|
2023
Q3 | $244K | Sell |
7,356
-517
| -7% | -$17.1K | 0.07% | 141 |
|
2023
Q2 | $289K | Sell |
7,873
-1,793
| -19% | -$65.8K | 0.08% | 136 |
|
2023
Q1 | $394K | Sell |
9,666
-1,470
| -13% | -$60K | 0.11% | 125 |
|
2022
Q4 | $571K | Buy |
11,136
+2,953
| +36% | +$151K | 0.16% | 106 |
|
2022
Q3 | $358K | Buy |
8,183
+204
| +3% | +$8.93K | 0.12% | 124 |
|
2022
Q2 | $418K | Buy |
7,979
+2
| +0% | +$105 | 0.13% | 113 |
|
2022
Q1 | $413K | Sell |
7,977
-45
| -0.6% | -$2.33K | 0.11% | 119 |
|
2021
Q4 | $474K | Buy |
8,022
+140
| +2% | +$8.27K | 0.12% | 118 |
|
2021
Q3 | $339K | Buy |
7,882
+2,323
| +42% | +$99.9K | 0.09% | 123 |
|
2021
Q2 | $218K | Hold |
5,559
| – | – | 0.06% | 136 |
|
2021
Q1 | $201K | Hold |
5,559
| – | – | 0.06% | 140 |
|
2020
Q4 | $205K | Buy |
5,559
+1,459
| +36% | +$53.8K | 0.06% | 137 |
|
2020
Q3 | $143K | Buy |
+4,100
| New | +$143K | 0.05% | 141 |
|
2019
Q4 | – | Sell |
-2,226
| Closed | -$76K | – | 398 |
|
2019
Q3 | $76K | Buy |
+2,226
| New | +$76K | 0.03% | 191 |
|
2017
Q4 | – | Sell |
-3,473
| Closed | -$118K | – | 257 |
|
2017
Q3 | $118K | Buy |
3,473
+708
| +26% | +$24.1K | 0.05% | 133 |
|
2017
Q2 | $88K | Buy |
+2,765
| New | +$88K | 0.04% | 144 |
|